antitumor activity of emodin against pancreatic cancer depends on its dual role promotion of apoptosis and suppression of angiogenesis抗肿瘤活性的大黄素对胰腺癌取决于其双重作用促进细胞凋亡和抑制血管生成.pdf
文本预览下载声明
Antitumor Activity of Emodin against Pancreatic Cancer
Depends on Its Dual Role: Promotion of Apoptosis and
Suppression of Angiogenesis
1,3 . 2. 3. 1 3 3
Sheng-Zhang Lin * , Wei-Tian Wei , Hui Chen , Kang-Jie Chen , Hong-Fei Tong , Zhao-Hong Wang ,
3 3 3 3
Zhong-Lin Ni , Hai-Bin Liu , Hong-Chun Guo , Dian-Lei Liu
1 Department of Hepato-biliary-pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 2 Department of Oncological
Surgery, Zhejiang Cancer Hospital, Hangzhou, China, 3 Department of Hepato-biliary-pancreatic Surgery, Second Affiliated Hospital of Wenzhou Medical College,
Zhejiang, China
Abstract
Background: Emodin has been showed to induce apoptosis of pancreatic cancer cells and inhibit tumor growth in our
previous studies. This study was designed to investigate whether emodin could inhibit the angiogenesis of pancreatic
cancer tissues and its mechanism.
Methodology/Principal Finding: In accordance with our previous study, emodin inhibited pancreatic cancer cell growth,
induced apoptosis, and enhanced the anti-tumor effect of gemcitabine on pancreatic caner cells in vitro and in vivo by
inhibiting the activity of NF-kB. Here, for the first time, we demonstrated that emodin inhibited tumor angiogenesis in vitro
and in implanted pancreatic cancer tissues, decreased the expression of angiogenesis-associated factors (NF-kB and its
regulated factors VEGF, MMP-2, MMP-9, and eNOS), and reduced eNOS phosphorylation, as evidenced by both
显示全部